Patents by Inventor Jennifer Le Couter

Jennifer Le Couter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110151468
    Abstract: Disclosed herein are methods and compositions useful for identifying therapies likely to confer optimal clinical benefit for patients with cancer.
    Type: Application
    Filed: November 19, 2010
    Publication date: June 23, 2011
    Applicant: Genetech, Inc.
    Inventors: Thomas D. Wu, Daniel Shin-Yu Chen, Jennifer Le Couter
  • Patent number: 7811984
    Abstract: The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Furthermore, methods of treatment using Bv8 polypeptides are provided.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: October 12, 2010
    Assignee: Genentech, Inc.
    Inventors: Napoleone Ferrara, Jennifer Le Couter
  • Patent number: 7709455
    Abstract: The present invention provides pharmaceutical compositions and methods for liver proliferation and protection. Specifically useful are VEGFR modulating agents capable of promoting liver growth. Disclosed compositions and methods may be useful for promoting proliferation or treating pathological conditions in other organs of significant biological functions.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: May 4, 2010
    Assignee: Genentech, Inc.
    Inventors: Napoleone Ferrara, Kenneth J Hillan, Jennifer Le Couter
  • Patent number: 7700571
    Abstract: The present invention provides pharmaceutical compositions and methods for liver proliferation and protection. Specifically useful are VEGFR modulating agents capable of promoting liver growth. Disclosed compositions and methods may be useful for promoting proliferation or treating pathological conditions in other organs of significant biological functions.
    Type: Grant
    Filed: June 5, 2003
    Date of Patent: April 20, 2010
    Assignee: Genentech, Inc.
    Inventors: Napoleone Ferrara, Kenneth J. Hillan, Jennifer Le Couter
  • Publication number: 20090123930
    Abstract: Disclosed herein are methods and compositions useful for identifying therapies likely to confer optimal clinical benefit for patients with cancer.
    Type: Application
    Filed: November 5, 2008
    Publication date: May 14, 2009
    Inventors: Thomas D. Wu, Daniel Shin-Yu Chen, Jennifer Le Couter
  • Publication number: 20070244063
    Abstract: The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Furthermore, methods of treatment using Bv8 polypeptides are provided.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 18, 2007
    Applicant: Genentech, Inc.
    Inventors: NAPOLEONE FERRARA, Jennifer Le Couter
  • Publication number: 20070122394
    Abstract: The present invention provides pharmaceutical compositions and methods for liver proliferation and protection. Specifically useful are VEGFR modulating agents capable of promoting liver growth. Disclosed compositions and methods may be useful for promoting proliferation or treating pathological conditions in other organs of significant biological functions.
    Type: Application
    Filed: September 25, 2006
    Publication date: May 31, 2007
    Applicant: Genentech, Inc.
    Inventors: Napoleone Ferrara, Kenneth Hillan, Jennifer Le Couter
  • Publication number: 20060204510
    Abstract: The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Furthermore, methods of treatment using Bv8 polypeptides are provided.
    Type: Application
    Filed: March 17, 2006
    Publication date: September 14, 2006
    Applicant: Genentech, Inc.
    Inventors: Napoleone Ferrara, Jennifer Le Couter
  • Patent number: 7060278
    Abstract: The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Furthermore, methods of treatment using Bv8 polypeptides are provided.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: June 13, 2006
    Assignee: Genentech, Inc.
    Inventors: Napoleone Ferrara, Jennifer Le Couter
  • Publication number: 20040170613
    Abstract: The present invention provides pharmaceutical compositions and methods for liver proliferation and protection. Specifically useful are VEGFR modulating agents capable of promoting liver growth. Disclosed compositions and methods may be useful for promoting proliferation or treating pathological conditions in other organs of significant biological functions.
    Type: Application
    Filed: June 5, 2003
    Publication date: September 2, 2004
    Applicant: Genentech, Inc.
    Inventors: Napoleone Ferrara, Kenneth J. Hillan, Jennifer Le Couter
  • Publication number: 20030092623
    Abstract: The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Furthermore, methods of treatment using Bv8 polypeptides are provided.
    Type: Application
    Filed: August 27, 2002
    Publication date: May 15, 2003
    Inventors: Napoleone Ferrara, Jennifer Le Couter